Does CARFILZOMIB Cause Cholecystitis acute? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Cholecystitis acute have been filed in association with CARFILZOMIB (KYPROLIS). This represents 0.1% of all adverse event reports for CARFILZOMIB.
12
Reports of Cholecystitis acute with CARFILZOMIB
0.1%
of all CARFILZOMIB reports
0
Deaths
12
Hospitalizations
How Dangerous Is Cholecystitis acute From CARFILZOMIB?
Of the 12 reports, 12 (100.0%) required hospitalization, and 1 (8.3%) were considered life-threatening.
Is Cholecystitis acute Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CARFILZOMIB. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does CARFILZOMIB Cause?
Plasma cell myeloma (2,238)
Off label use (2,120)
Death (1,442)
Thrombocytopenia (1,265)
Fatigue (1,048)
Pneumonia (1,016)
Pyrexia (969)
Anaemia (910)
Dyspnoea (881)
Neutropenia (874)
What Other Drugs Cause Cholecystitis acute?
LENVATINIB (124)
RITUXIMAB (111)
YAZ (109)
YASMIN (103)
DEXAMETHASONE (99)
METHOTREXATE (98)
PEMBROLIZUMAB (94)
SEMAGLUTIDE (93)
ASPIRIN (84)
LENALIDOMIDE (84)
Which CARFILZOMIB Alternatives Have Lower Cholecystitis acute Risk?
CARFILZOMIB vs CARGLUMIC ACID
CARFILZOMIB vs CARIPRAZINE
CARFILZOMIB vs CARISOPRODOL
CARFILZOMIB vs CARMUSTINE
CARFILZOMIB vs CARTEOLOL